While prior reports of concomitant osteosarcoma and OI have involved other subtypes, this case represents the first documented true co-occurrence in a patient with <i>IFITM5</i>-related OI and underscores the importance of recognizing the overlapping and divergent features of these conditions when rendering a diagnosis and initiating treatment protocols. This evidence concerns the gene IFITM5 and osteosarcoma.